Ye Liu, Director at EyePoint Pharmaceuticals, Inc. (EYPT), sold 1,910,500 shares at $19.45 ($37.2M) on 2024-01-11, disclosed to the SEC on 2024-01-16.
Open-market sale of $37.2M EYPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |